Researchers will test the drugs against the disease after finding prostate cancer cells were more likely to duplicate and ...

New research from Cornell University reveals that GLP-1 weight-loss medications are significantly altering American shopping ...

India's obesity drug market is experiencing rapid growth, driven by rising lifestyle diseases and the launch of blockbuster ...

Major stock indexes ended higher for a fourth straight session Tuesday, with the S&P 500 setting a fresh closing record, ...

The Danish drugmaker will start selling a pill version of its Wegovy weight-loss medicine in January, after [securing ...

As GLP-1 weight-loss drugs become more common, their effects may be reshaping everyday food choices in ways that extend far beyond individual health. When people in the United States begin using ...

Packaged food makers and fast-food restaurants may be forced to overhaul more of their products next year as newly approved, appetite-suppressing GLP-1 pills become available in January, analysts say.

U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

But Eli Lilly's Zepbound is best in class. Zepbound caused greater average weight loss than Wegovy in a head-to-head study. And through the first nine months of 2025, Zepbound generated $9.3 billion ...

The Best Weight Loss Supplements for Women This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: The best ...

While patients currently must get weekly injections of the weight loss drug Wegovy, the FDA has now approved a daily pill version of the product. After spending most of his life back and forth from ...

The American Academy of Pediatrics sued the U.S. Department of Health and Human Services on Wednesday, seeking to block ...